Human medicines European public assessment report (EPAR): Myfenax, mycophenolate mofetil, Graft Rejection, Date of authorisation: 21/02/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Brimica Genuair, aclidinium,formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 19/11/2014, Revision: 14, Status: Authorised

MedDRA Important medical event terms list - version 26.1

Vaccine Monitoring Platform

List of medicinal products under additional monitoring

Human medicines European public assessment report (EPAR): Bevespi Aerosphere, glycopyrronium,formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Prostatic Neoplasms, Date of authorisation: 26/04/2021, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Angiofibroma;Tuberous Sclerosis, Date of authorisation: 15/05/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Invirase, saquinavir, HIV Infections, Date of authorisation: 03/10/1996, Revision: 50, Status: Withdrawn

Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Contraception, Postcoital, Date of authorisation: 15/05/2009, Revision: 30, Status: Authorised